These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

778 related items for PubMed ID: 16035948

  • 1. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM, Latham T, Cupo A.
    Viral Immunol; 2005; 18(2):365-72. PubMed ID: 16035948
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE, Flyer DC, Raghunandan R, Liu Y, Wei Z, Wu Y, Kpamegan E, Courbron D, Fries LF, Glenn GM.
    Vaccine; 2013 Sep 13; 31(40):4305-13. PubMed ID: 23891795
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
    Matassov D, Cupo A, Galarza JM.
    Viral Immunol; 2007 Sep 13; 20(3):441-52. PubMed ID: 17931114
    [Abstract] [Full Text] [Related]

  • 7. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice.
    Tao P, Luo M, Zhu D, Qu S, Yang Z, Gao M, Guo D, Pan Z.
    Viral Immunol; 2009 Jul 13; 22(4):273-81. PubMed ID: 19594398
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.
    Ji X, Ren Z, Xu N, Meng L, Yu Z, Feng N, Sang X, Li S, Li Y, Wang T, Zhao Y, Wang H, Zheng X, Jin H, Li N, Yang S, Cao J, Liu W, Gao Y, Xia X.
    Viruses; 2016 Apr 21; 8(4):115. PubMed ID: 27110810
    [Abstract] [Full Text] [Related]

  • 10. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.
    Quan FS, Huang C, Compans RW, Kang SM.
    J Virol; 2007 Apr 21; 81(7):3514-24. PubMed ID: 17251294
    [Abstract] [Full Text] [Related]

  • 11. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
    Mahmood K, Bright RA, Mytle N, Carter DM, Crevar CJ, Achenbach JE, Heaton PM, Tumpey TM, Ross TM.
    Vaccine; 2008 Oct 03; 26(42):5393-9. PubMed ID: 18706956
    [Abstract] [Full Text] [Related]

  • 12. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.
    Chen Z, Matsuo K, Asanuma H, Takahashi H, Iwasaki T, Suzuki Y, Aizawa C, Kurata T, Tamura S.
    Vaccine; 1999 Feb 26; 17(7-8):653-9. PubMed ID: 10067670
    [Abstract] [Full Text] [Related]

  • 13. Protective efficacy of baculovirus-derived influenza virus-like particles bearing H5 HA alone or in combination with M1 in chickens.
    Choi JG, Kim MC, Kang HM, Kim KI, Lee KJ, Park CK, Kwon JH, Kim JH, Lee YJ.
    Vet Microbiol; 2013 Mar 23; 162(2-4):623-630. PubMed ID: 23265240
    [Abstract] [Full Text] [Related]

  • 14. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
    Latham T, Galarza JM.
    J Virol; 2001 Jul 23; 75(13):6154-65. PubMed ID: 11390617
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of the protection afforded by triple baculovirus recombinant coexpressing H5, N3, M1 proteins against a homologous H5N3 low-pathogenicity avian influenza virus challenge in Muscovy ducks.
    Prel A, Le Gall-Reculé G, Cherbonnel M, Grasland B, Amelot M, Jestin V.
    Avian Dis; 2007 Mar 23; 51(1 Suppl):484-9. PubMed ID: 17494615
    [Abstract] [Full Text] [Related]

  • 17. Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza.
    Hossain MJ, Bourgeois M, Quan FS, Lipatov AS, Song JM, Chen LM, Compans RW, York I, Kang SM, Donis RO.
    Clin Vaccine Immunol; 2011 Dec 23; 18(12):2010-7. PubMed ID: 22030367
    [Abstract] [Full Text] [Related]

  • 18. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
    Pillet S, Racine T, Nfon C, Di Lenardo TZ, Babiuk S, Ward BJ, Kobinger GP, Landry N.
    Vaccine; 2015 Nov 17; 33(46):6282-9. PubMed ID: 26432915
    [Abstract] [Full Text] [Related]

  • 19. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K, Lange E, Blohm U, Teifke JP, Mettenleiter TC, Fuchs W.
    Virus Res; 2015 Mar 02; 199():20-30. PubMed ID: 25599604
    [Abstract] [Full Text] [Related]

  • 20. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.
    Pushko P, Tumpey TM, Bu F, Knell J, Robinson R, Smith G.
    Vaccine; 2005 Dec 30; 23(50):5751-9. PubMed ID: 16143432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.